Showing results (1-10 of 1,670) with videos related to
Sort By:
Pageof 167
Current Topics in Medicinal Chemistry|March 6, 2024
Highlights on Fluorine-containing Drugs Approved by U.S. FDA in 2023Saghir Ali, Andrew A Bolinger, Jia ZhouDrug Discovery Today|April 12, 2026
Artificial intelligence revolutionizing CNS drug discovery and developmentMd E K Talukder, Mohammad R Islam, Saghir Ali, et al.European Journal of Medicinal Chemistry|May 19, 2023
Highlights on U.S. FDA-approved fluorinated drugs over the past five years (2018-2022)Saghir Ali, Jia ZhouExpert Opinion on Drug Discovery|March 10, 2023
Novel approaches to targeted protein degradation technologies in drug discoveryYu Xue, Andrew A Bolinger, Jia ZhouDrug Discovery Today|September 21, 2023
RIPTACs: A groundbreaking approach to drug discoveryZonghui Ma, Andrew A Bolinger, Jia ZhouExpert Opinion on Therapeutic Targets|January 30, 2023
Bromodomain-containing protein 4 (BRD4): a key player in inflammatory bowel disease and potential to inspire epigenetic therapeuticsZonghui Ma, Andrew A Bolinger, Jia Zhou, et al.Journal of Medicinal Chemistry|August 14, 2023
Drug Discovery Targeting Nuclear Receptor Binding SET Domain Protein 2 (NSD2)Zonghui Ma, Andrew A Bolinger, Haiying Chen, et al.Expert Opinion on Therapeutic Patents|September 2, 2024
An updated patent review of BRD4 degradersZonghui Ma, Cun Zhang, Andrew A Bolinger, et al.Expert Opinion on Drug Discovery|July 30, 2024
Lessons learnt from broad-spectrum coronavirus antiviral drug discoveryAndrew A Bolinger, Jun Li, Xuping Xie, et al.Advances in Pharmacology (San Diego, Calif.)|November 9, 2024
BRD4 as an emerging epigenetic therapeutic target for inflammatory bowel diseaseZonghui Ma, Andrew A Bolinger, Irina V Pinchuk, et al.Pageof 167